Form 8-K - Current report:
SEC Accession No. 0001372514-24-000117
Filing Date
2024-10-29
Accepted
2024-10-29 07:00:23
Documents
56
Period of Report
2024-10-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20241029.htm   iXBRL 8-K 28538
2 EX-99.1 ex991-approvaltoinitiateab.htm EX-99.1 13830
3 EX-99.2 ex992-kiorapharmaovervie.htm EX-99.2 37092
7 ex992-kiorapharmaovervie001.jpg GRAPHIC 45124
8 ex992-kiorapharmaovervie002.jpg GRAPHIC 185314
9 ex992-kiorapharmaovervie003.jpg GRAPHIC 66568
10 ex992-kiorapharmaovervie004.jpg GRAPHIC 65878
11 ex992-kiorapharmaovervie005.jpg GRAPHIC 91882
12 ex992-kiorapharmaovervie006.jpg GRAPHIC 73028
13 ex992-kiorapharmaovervie007.jpg GRAPHIC 37722
14 ex992-kiorapharmaovervie008.jpg GRAPHIC 65120
15 ex992-kiorapharmaovervie009.jpg GRAPHIC 83861
16 ex992-kiorapharmaovervie010.jpg GRAPHIC 100363
17 ex992-kiorapharmaovervie011.jpg GRAPHIC 67959
18 ex992-kiorapharmaovervie012.jpg GRAPHIC 75119
19 ex992-kiorapharmaovervie013.jpg GRAPHIC 44261
20 ex992-kiorapharmaovervie014.jpg GRAPHIC 108018
21 ex992-kiorapharmaovervie015.jpg GRAPHIC 89251
22 ex992-kiorapharmaovervie016.jpg GRAPHIC 35393
23 ex992-kiorapharmaovervie017.jpg GRAPHIC 84948
24 ex992-kiorapharmaovervie018.jpg GRAPHIC 88084
25 ex992-kiorapharmaovervie019.jpg GRAPHIC 84477
26 ex992-kiorapharmaovervie020.jpg GRAPHIC 48822
27 ex992-kiorapharmaovervie021.jpg GRAPHIC 85676
28 ex992-kiorapharmaovervie022.jpg GRAPHIC 90024
29 ex992-kiorapharmaovervie023.jpg GRAPHIC 116183
30 ex992-kiorapharmaovervie024.jpg GRAPHIC 65682
31 ex992-kiorapharmaovervie025.jpg GRAPHIC 86089
32 ex992-kiorapharmaovervie026.jpg GRAPHIC 74667
33 ex992-kiorapharmaovervie027.jpg GRAPHIC 82865
34 ex992-kiorapharmaovervie028.jpg GRAPHIC 91468
35 ex992-kiorapharmaovervie029.jpg GRAPHIC 92396
36 ex992-kiorapharmaovervie030.jpg GRAPHIC 69868
37 ex992-kiorapharmaovervie031.jpg GRAPHIC 84878
38 ex992-kiorapharmaovervie032.jpg GRAPHIC 68434
39 ex992-kiorapharmaovervie033.jpg GRAPHIC 108405
40 ex992-kiorapharmaovervie034.jpg GRAPHIC 72968
41 ex992-kiorapharmaovervie035.jpg GRAPHIC 75094
42 ex992-kiorapharmaovervie036.jpg GRAPHIC 82327
43 ex992-kiorapharmaovervie037.jpg GRAPHIC 109356
44 ex992-kiorapharmaovervie038.jpg GRAPHIC 112214
45 ex992-kiorapharmaovervie039.jpg GRAPHIC 90141
46 ex992-kiorapharmaovervie040.jpg GRAPHIC 58253
47 ex992-kiorapharmaovervie041.jpg GRAPHIC 35477
  Complete submission text file 0001372514-24-000117.txt   4767161

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20241029.xsd EX-101.SCH 1800
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20241029_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20241029_pre.xml EX-101.PRE 13058
58 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20241029_htm.xml XML 2814
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 241402643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)